Cardiovascular comorbidities are increased in US patients with haemophilia A: A retrospective database analysis

Haemophilia

Volumn 20, Issue 4, 2014, Pages 472-478

  Pocoski, J ^a   Ma, A ^b   Kessler, C M ^c   Boklage, S ^d   Humphries, T J ^e  

^a Global Health Economics and Outcomes Research Bayer HealthCare   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^c GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

^d OTSUKA PHARMACEUTICAL DEVELOPMENT AND COMMERCIALIZATION INC   (United States)

^e US Medical Affairs Bayer HealthCare   (United States)

Author keywords

Cardiovascular comorbidities; Cardiovascular disease; Haemophilia

Indexed keywords

BLOOD CLOTTING FACTOR 8;

ADULT; ARTERY THROMBOSIS; ARTICLE; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CARDIOVASCULAR DISEASE; CEREBROVASCULAR ACCIDENT; COMORBIDITY; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DATA BASE; HEALTH INSURANCE; HEALTH MAINTENANCE ORGANIZATION; HEART INFARCTION; HEMOPHILIA A; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERLIPIDEMIA; HYPERTENSION; ICD-9-CM; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCREENING; SENSITIVITY ANALYSIS; UNITED STATES; VEIN THROMBOSIS; ADOLESCENT; AGED; CARDIOVASCULAR DISEASES; CHILD; FACTUAL DATABASE; FEMALE; INFANT; MIDDLE AGED; NEWBORN; PRESCHOOL CHILD; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; CARDIOVASCULAR DISEASES; CHILD; CHILD, PRESCHOOL; COMORBIDITY; DATABASES, FACTUAL; FEMALE; HEMOPHILIA A; HUMANS; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; PREVALENCE; RETROSPECTIVE STUDIES; UNITED STATES; YOUNG ADULT;

EID: 84904747564     PISSN: 13518216     EISSN: 13652516     Source Type: Journal    
DOI: 10.1111/hae.12339     Document Type: Article

References (27)

1. Soucie JM, Evatt B, Jackson D. Occurrence of haemophilia in the United States. The Haemophilia Surveillance System Project Investigators. Am J Hematol 1998; 59: 288-94.
2. Centers for Disease Control and Prevention. Haemophilia Facts. Available at http://www.cdc.gov/ncbddd/haemophilia/facts.html. Accessed March 1, 2013.
3. Philipp C. The aging patient with haemophilia: complications, comorbidities, and management issues. Hematol Am Soc Hematol Educ Program 2010; 2010: 191-6.
4. Mannucci PM. Management of antithrombotic therapy for acute coronary syndromes and atrial fibrillation in patients with haemophilia. Expert Opin Pharmacother 2012; 13: 505-10.
5. Darby SC, Kan SW, Spooner RJ et al. Mortality rates, life expectancy, and causes of death in people with haemophilia A or B in the United Kingdom who were not infected with HIV. Blood 2007; 110: 815-25.
6. Biere-Rafi S, Zwiers M, Peters M et al. The effect of haemophilia and von Willebrand disease on arterial thrombosis: a systematic review. Neth J Med 2010; 68: 207-14.
7. Tuinenburg A, Mauser-Bunschoten EP, Verhaar MC, Biesma DH, Schutgens RE. Cardiovascular disease in patients with haemophilia. J Thromb Haemost 2009; 7: 247-54.
8. Biere-Rafi S, Tuinenburg A, Haak BW et al. Factor VIII deficiency does not protect against atherosclerosis. J Thromb Haemost 2012; 10: 30-7.
9. Biere-Rafi S, Baarslag MA, Peters M et al. Cardiovascular risk assessment in haemophilia patients. Thromb Haemost 2011; 105: 274-8.
10. Fransen van de Putte DE, Fischer K, Makris M, Tait RC, Chowdary P, Collins PW. Unfavourable cardiovascular disease risk profiles in a cohort of Dutch and British haemophilia patients. Thromb Haemost 2012; 109: 16-23.
11. Kulkarni R, Soucie JM, Evatt BL. Haemophilia Surveillance System Project Investigators. Prevalence and risk factors for heart disease among males with haemophilia. Am J Hematol 2005; 79: 36-42.
12. Soucie JM, Nuss R, Evatt B et al. Mortality among males with hemophilia: relations with source of medical care. The Hemophilia Surveillance System Project Investigators. Blood 2000; 96: 437-42.
13. Ragni MV, Moore CG. Atherosclerotic heart disease: prevalence and risk factors in hospitalized men with haemophilia A. Haemophilia 2011; 17: 867-71.
14. Sharathkumar AA, Soucie JM, Trawinski B, Greist A, Shapiro AD. Prevalence and risk factors of cardiovascular disease (CVD) events among patients with haemophilia: experience of a single haemophilia treatment centre in the United States (US). Haemophilia 2011; 17: 597-604.
15. Hansen LG, Chang S. White Paper: Health Research Data for the Real World: The MarketScan Databases. Ann Arbor, MI: Truven Health Analytics, 2011.
16. Go AS, Hylek EM, Phillips KA et al. Prevalence of diagnosed atrial fibrillation in adults. JAMA 2001; 285: 2370-5.
17. Wang L, Wei W, Miao R, Xie L, Baser O. Real-world outcomes of US employees with type 2 diabetes mellitus treated with insulin glargine or neutral protamine hagedorn insulin: a comparative retrospective database study. BMJ Open 2013; 30: 1-9.
18. Valentino LA, Pipe SW, Tarantino MD, Ye X, Xiong Y, Luo MP. Healthcare resource utilization among haemophila A patients in the US. Haemophilia 2012; 18: 332-8.
19. Guh S, Grosse SD, McAlister S, Kessler CM, Soucie JM. Healthcare expenditures for males with haemophilia and employer-sponsored insurance in the United States, 2008. Haemophilia 2012; 18: 268-75.
20. Witmer C, Presley R, Kulkarni R, Soucie JM, Manno CS, Raffini L. Associations between intracranial haemorrhage and prescribed prophylaxis in a large cohort of haemophilia patients in the United States. Br J Haematol 2011; 152: 211-6.
21. Ruiz-Saez A. Thrombosis in rare bleeding disorders. Hematology 2012; 17(Suppl. 1): S156-8.
22. Hermans C, Hammer F, Lobet S, Lambert C. Subclinical deep venous thrombosis observed in 10% of hemophilic patients undergoing major orthopedic surgery. J Thromb Haemost 2010; 8: 1138-40.
23. Jenkins PV, Rawley O, Smith OP, O-Donnell JS. Elevated factor VIII levels and risk of venous thrombosis. Br J Haematol 2012; 157: 653-63.
24. Stein JH. Carotid artery imaging: insights into inflammation and cardiovascular disease risk in patients with HIV infection. J Am Heart Assoc 2012; 1: e001396.
25. Kakinami L, Block RC, Adams MJ, Cohn SE, Maliakkal B, Fisher SG. Risk of cardiovascular disease in HIV, hepatitis C, or HIV, /hepatitis C patients compared to the general population. Int J Clin Pract 2013; 67: 6-13.
26. Freiberg MS, Chang CC, Kuller LH et al. HIV infection and the risk of acute myocardial infarction. JAMA Intern Med 2013; 173: 614-22.
27. Malaviya AP, Hall FC. Targeting CVD risk in chronic connective tissue disease. Practitioner 2012; 256: 21-6.